Back to Dashboard
DVA · Healthcare

Davita Inc

USA Healthcare Filing: 2026-06-30
36/100
Smart-money confidence1 of 3 sources positive
Below average interest

No standout activity across the feeds we track.

What this band has actually done: stocks scoring 0–25 beat the S&P 500 over the next three months 39.9% of the time, across 100,496 cases since 2015. That is below a coin flip — and so is every other band, because the median stock loses to a cap-weighted index. How we measured this

Hedge funds
48
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Market cap
$11.2B
Industry
Medical Care Facilities
Sector
Healthcare
Exchange
NYSE
About DAVITA INC

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and…

Who's behind the signal
Every informed buyer we can see on DVA, across all three feeds.
Hedge funds · 9
D.E. Shaw & Co Increased +27%
AQR Capital Management Increased +43%
+3 more in the full breakdown below ↓
Congress · 3
Jerry Moran bought
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 5 on record
Disclosures from 2018-12-06 to 2026-03-27
Trade date Member Chamber Action Amount
2026-03-27 Alan Armstrong · R-OK Senate Bought $1,001 - $15,000
2025-09-25 Julie Johnson · D-TX House Sold $1,001 - $15,000
2025-09-23 Julie Johnson · D-TX House Bought $1,001 - $15,000
2025-09-23 Julie Johnson · D-TX House Sold $1,001 - $15,000
2018-12-06 Jerry Moran · R-KS Senate Bought $1,001 - $15,000
Not a model pick — but on our radar. DAVITA INC isn't in the top-10 model right now, but 9 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
9
Investors
0
New positions
3
Increasing
6
Decreasing
0
Unchanged
Price History
Loading price data...
A member of Congress bought A member sold
Return: High: Low:

Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.

Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Portfolio Allocation
How much of each investor's portfolio is allocated to DAVITA INC
Insider Trading (Form 4)
Recent trades by company officers and directors — filed within 2 days of each trade
Neutral
Sentiment
0
Buys
5
Sells
Date Insider Title Action Shares Price Value
2026-07-31 BERKSHIRE HATHAWAY INC Insider SELL 182,980 $199.55 $36,513,293
2026-06-16 Rodriguez Javier Insider SELL 39,407 $209.28 $8,247,018
2026-06-15 Waters Kathleen Alyce Insider SELL 6,455 $209.17 $1,350,173
2026-06-15 Waters Kathleen Alyce Insider SELL 8,950 $207.84 $1,860,204
2026-06-15 Rodriguez Javier Insider SELL 30,000 $209.50 $6,285,090
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell DAVITA INC or any security.

Get the Weekly Update

Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime